Nanotechnology Effective On Cancer: during the treatment of cancer, chemotherapy is given continuous medication. After some time, it's seen that the cancer within the patient develops drug registers. After this, doctors are obliged to give high dose medication to the patient. Shortly thereafter, that drug also becomes effective against cancer.

This is because the condition of multidrug registers in the cells. A special drug has been prepared through nanotechnology by the biomedical Department of IIT BHU, Varanasi which will} be able to save patients despite multidrug registrations. Trials are underway in Hyderabad on this nano-metalsorafenib conjugates drug.

Statistics show that around 70 % of individuals affected by cancer fall victim to this multi-drug registration. More than 70 % of the patients suffering from these lose their lives. Keeping this problem in mind, Dr. Marshall Dhayal of the biomedical Department at IIT, BHU started analysis four years ago. He also got success that goes to be a boon for cancer patients in the future. He explained that around the cell of the human body there are receptor molecules in the shape of the antenna, that carry the elements of the drug inside the cell. Repeated medication makes the receptor ineffective. Multi-drug registers arise in cancer cells. In such a situation, when therapy is given in the cancer cells, the effect isn't there. When all the doors of medicines are closed, then the patient's life is in danger.

Dr. Marshall told me that there are nano-sized holes on the cells that don't attach to the chemical substance. Now the only way to send the medicine to those cells is that the nanosize holes through that a drug of 2.5 to 5-nanometer size is inserted. Keeping this in mind, the Nano-metallosoraphenib conjugates drug was formulated. In this way, only particles developed from nanotechnology enter these holes and kill cancer cells with drug registrations and nondrug registrations. Apart from this, there's no additional side effect of these drugs, because the dose of the drug is reduced by ninety percent.

Dr. Marshall said that the Deccan college of medical science, based in Hyderabad, played a very necessary role in this analysis work. Apart from IIT BHU, trials are going on in the lab of Deccan college, which are seeing great effects. Soon, its clinical trial can begin on humans too. Dr. Marshall's research has also been revealed in the journal Scientific Reports of Nature publishing house, a UK-based publisher. In the next part of this research, work is also being done on how the use of this nanomedicine is possible to prevent cancer after cancer surgery. IIT BHU has applied for a patent for this related technology.

The figures are worrying
Every year in India, about 17 lakh individuals succumb to cancer, whereas seven lakh individuals lose their lives every year due to drug registrations. The worrying issue in this is that by 2050 this number will reach one crore.